9 : : : : : : : : : 00
|
|
|
- せとか かみこ
- 7 years ago
- Views:
Transcription
1
2 9 : : : : : : : : : 00
3 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは cm 位 です 文 字 数 書 体 文 字 のサイズは 特 に 指 定 しません 3. 演 題 番 号 (20 20cm)は 医 学 会 事 務 局 で 用 意 します 4. 展 示 ボードへの 貼 り 付 けは 会 場 内 に 用 意 してあります 画 鋲 を 使 用 してください 20cm 70cm 演 題 番 号 演 題 所 属 氏 名 発 表 者 各 自 でご 用 意 ください 20cm 医 学 会 で 用 意 し ま す 85cm ポスター 掲 示 範 囲 155cm 160cm
4 / 1 Targeting aggresome formation under simultaneous inhibition of proteasome and autophagy potentiates ER - stress mediated cell death in myeloma cells IIB VI 6 3 Selective vulnerability and dispersion of dentate granule cells and their progenitors in pilocarpine - induced status epilepticus rat model 4 4Temporal progression of hypothalamic patterning by BMP BMP 1 2 3Therapeutic potential of fingolimod and sphingosine kinases inhibitors in myeloma cells
5
6 P P1-2 Candida β - glucan NETs : : P1-3 Acinetobacter baumannii complex 4 P P1-5 MALDITOF MS 4 1 P1-6 SV2A School of Pharmacy, University of Reading Vogl Christian, Stephens Gary J P1-7 P1-8 P2Y2 P1-9 P1-10 Low - grade overexpression of nuclear FUS induces neuronal cell death 1 P1-11 P1-12 :
7 P1-13 HIV : : P1-14 P P1-16 P P1-18 Progesterone effects in the brain microcirculation after TBI : How do standard osmotherapies compare? : P1-19 : P P P2-22 CHF 4 P2-23
8 P2-24 PNF 4 2 P2-25Usefulness of saturated salt solution method for surgical training : A empirical research P2-26 mir : P2-27 P2-28 IMiDs GUPTA VIPUL 3 P P2-30 P2-31 Th17 P2-32 PMX - DHP : 4 P2-33 TRPM7 Mg 2+ P2-34 Characterization of model mice for nuclear envelopathies P2-35 bfgf S100A9 P P2-37 Decorin
9 2 P2-38 P2-39 P2-40 Restless legs syndrome symptom during the daytime in Japanese population 3 P2-41 / JR : NTT : P2-42 West 1 P3-43 EGFR - independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non - small cell lung cancer cells 5 4 P3-44 GSK3 β inhibitors : PI3K P3-45 P3-46 : : 2 P3-47
10 P3-48 Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma 4 P P P3-51 IL - 27 M1 2 : : P3-52 : P3-53 : : P3-54 Circulating Tumor Cell : P3-55 BCL2L11 BIM : : 5 P3-56 iges
11 P3-57 KCNQ1 2 SNP DNA P3-58 Th2 Cytokines Enhances IL - 12p70 Secretion from Human Dendritic Cells Stimulated with CD40L + IFN γ. - P3-59 IL - 33 promotes ICAM - 1 expression via NF - kb in murine mast cells 3 G G G G G G G G G - 9 6
日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
2
2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary
08-g-”O−}„j‹ê-4.02
200( 96 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 2 Apr. 585 1 17 MIC 1. (Transtracheal aspiration: TTA) TTA TTA TTA 1400 TTA (diffuse panbronchiolitis, DPB) 1) erythromycin(em) EM 12.5% 87.5% 2,3) EM EM
untitled
The 42 nd Annual Meeting of Japan Brain Science society 42 2015 111213 42 1. 2. 3. 4. 5. 1. 2. 3. 4. 10 http://www.anahirmiyazaki.com/ 10 269 220 ANA 2 2 1000 1016 930 946 1110 1126 1040 1056 1340 1356
平成１４年度 本態性多種化学物質過敏状態の調査研究 研究報告書
226 227 µ 228 Ω 229 230 0 ppb 2000ppb DG subthreshold (µa) 91 ± 59 86 ± 68 max stim. (µa) 755 ± 287 n=37 678 ± 300 max PS (mv) 8.7 ± 3.9 7.7 ± 4.3 n=61 CA1 subthreshold (µa) 36 ± 26 32 ± 13 max stim. (µa)
「諸雑公文書」整理の中間報告
30 10 3 from to 10 from to ( ) ( ) 20 20 20 20 20 35 8 39 11 41 10 41 9 41 7 43 13 41 11 42 7 42 11 41 7 42 10 4 4 8 4 30 10 ( ) ( ) 17 23 5 11 5 8 8 11 11 13 14 15 16 17 121 767 1,225 2.9 18.7 29.8 3.9
untitled
1999 4,138 4,000 20042005 10 10 856 0.5 () 2003 3 () ( 20 ) 1 2 3 4 6 7 9 11 20 22 24 28 35 37 41 41 42 45 46 48 55 65 2003 2004 2005 JR () () ()() () () 1 () () () () () 2 ((1985 ) 45 40 35 30 25 30 20
Fig. 1 Method of SRCA Table 1 Drug dose and treatment schedule in SRCA Table 2 Results of SRCA for renal cell carcinomas * Histological grading of the
SUBRENAL CAPSULE ASSAY FOR CHEMOSENSITIVITY TEST OF URINARY TRUCT CANCERS Jun Hasegawa, Yoshio Yamanaka, Kezutaka Horiuchi and Masao Akimoto Department of Urology, Nippon Medical School (Director: Prof.
ミニレビュー
Molecular mechanisms of the suppression of inflammation by thermal stress Ryosuke Takii Department of Biochemistry and Molecular Biology, Yamaguchi University Graduate School of Medicine, Ube 755-8505,
第124回日本医学会シンポジウム
III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2
12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
喘息について\(公健協会宛02-5作成\)
Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30
1315 (15)
(14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide
PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM.
PM2.5 5-1457 2628,685 PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM. PM2.5 PM2.5 PM.,, PM2.5 PM2.5 PM. PM2.5 PM. PM!"#$%&'()*+,-./0! TLR2! TLR4!!"1# 234# -35# 67! 89:! ;()!!"1# ?@"#$%AB! CD!
52-2.indb
Jpn. J. Health Phys., 52 (2) 55 60 (2017) DOI: 10.5453/jhps.52.55 * 1 * 2 * 2 * 3 * 3 2016 10 28 2017 3 8 Enhancement of Knowledge on Radiation Risk Yukihiko KASAI,* 1 Hiromi KUDO,* 2 Masahiro HOSODA,*
ALDEFLUOR® 造血幹細胞／造血前駆細胞の新しい同定試薬
ALDEFLUOR Immunophenotyping ALDEFLUOR Primitive Mature or ALDH Aldehyde Dehydrogenase(ALDH) ALDH Stemness ALDH Primitive Mature ALDEFLUOR Intracellular enzymatic assay ALDEFLUOR BAAA ALDH BAA ALDH BAA
..,,...,..,...,,.,....,,,.,.,,.,.,,,.,.,.,.,,.,,,.,,,,.,,, Becker., Becker,,,,,, Becker,.,,,,.,,.,.,,
J. of Population Problems. pp.,,,.,.,,. Becker,,.,,.,,.,,.,,,,.,,,.....,,. ..,,...,..,...,,.,....,,,.,.,,.,.,,,.,.,.,.,,.,,,.,,,,.,,, Becker., Becker,,,,,, Becker,.,,,,.,,.,.,, ,,, Becker,,., Becker,
14-2JAMTTCNL0913F
JAMTTC News Letter No.14-2 Sept. 2010 http://jamttc.umin.jp Japanese Association for Molecular Target Therapy of Cancer information September, 2010 1 News 2 Japanese Association for Molecular Target Therapy
一般演題（ポスター）
6 5 13 : 00 14 : 00 A μ 13 : 00 14 : 00 A β β β 13 : 00 14 : 00 A 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A
P1-1 P1-2 P1-3 P1-4 P1-5 P1-6 P3-1 P3-2 P3-3 P3-4 P3-5 P3-6 P5-1 P5-2 P5-3 P5-4 P5-5 P5-6 P7-1 P7-2 P7-3 P7-4 P7-5 P7-6 P9-1 P9-2 P9-3 P9-4 P9-5 P9-6 P11-1 P11-2 P11-3 P11-4 P13-1 P13-2 P13-3 P13-4 P13-5
レジャー産業と顧客満足の課題
1 1983 1983 2 3700 4800 5500 3300 15 3 100 1000 JR 4 14 2000 55% 72% 1878 2000 5 ( ) 22 1,040 5 946 42 15 25 30 30 4 14 39 1 24 8 6 390 33 800 34 34 3 35 () 37 40 1 50 40 46 47 2 55 4.43 4 16.98 40 55
Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy
Clinicopathological Studies on Cancerous Pleurisy, with Emphasis on Extra-Pulmonary Malignancy Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung
;~ (Summary) The Study on the Effects of Foot Bathing on Urination Kumiko Toyoda School of Human Nursing, University of Shiga Prefecture Background Foot bathing is one of the important nursing care for
1 Department of Legal Medicine, Toyama University School of Medicine 2 3 4 5 6 7 8 Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama VEGF Key words
Isotope News 2017年10月号 No.753
Ishioka Noriko ₁ はじめに RI RI RI RI ₂ 悪性褐色細胞腫と治療の現状 3,000 90 I meta- Iiodo-benzylguanidine I-MIBG 1 ₃ α 線の標的アイソトープ治療 2016 6 223 RaCl2 223 Ra 223 Ra 14 表 1 α 線と β 線の違い -decay (42%) Eα = 5.9 MeV At 7.2 h EC
*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati
*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combination with angiotensin II induced hyperten sion chemotherapy
12331514 20131126 1 2 3 1 2 2 52495 4 1122 1 2 2 2 3 45 1 2 1 3 2 4 Z 8305 1962 8 4 2 1 2 2 35 3 12 1 2 32 4418 4 1 5 323 6 11111 332 5 342 6 1 23 4 2 3 7 3 2 3 25175 19132 8 2 1 1 2 3 4 5 6 7 2 1 2 3
3 6 6 8 5 5 0 4 3 4 4 0,000 3 ID ID ID 4 7 9 :5 4 5 60-8048 NACOS TEL: 075-45-366 FAX: 075-45-366 E-mail: jiao@nacos.com 3. Power Point PC 0 5. Power Point PC 7 3 3. 3 5 PC PC PC Windows Power Point USB
研究成果報告書(基金分)
The most remarkable characteristic of the mammalian neocortex is its layered structure. Because all, but only the mammalian species, have this layered structure in the telencephalon, it has been accepted
Unknown
Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.3 July 2013 Report The 30 th Meeting of Japan Association of Breast and Thyroid Sonology... 1 Department of Organ
/‚“1/ŒxŒ{‚×›î’æ’¶
60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:
研究成果報告書
系 レニン 1. Ito D, Ito O, Mori N, Suda C, Hao K, Cao P, Muroya Y, Takashima K, Shimokawa H, Kohzuki M. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.
2004 10 2004 1984 2 1986 4 20 60 1 3 1 1 1 13,300 2 2 2 3 1 2004 2009 2 1 1 2 1 1985 97JR JT NTT 2002 96 97 4 JR JT 97 3 JR 19 29 JT 2.4 2.5 JR JT NTT JR JT NTT 2 97 4 JR 20.09 JT 19.92 NTT 17.35 17.35
Effects of the testosterone on both male and female fowls Shohyoe Tsuda Résumé This study was carried out to test the biological actions of androgen on both male and female fowls. As androgen "Amolisin"
日本消化器外科学会雑誌第30巻第3号
Key words : gastric cancer, progltostic factor. multivariate analysis Factors selected after Coffelation- after Stepwise rnitrally check check H o s t l A g e C O 2 S e x C O 3 Pre-op. compliation O Treatment
2 251 Barrera, 1986; Barrera, e.g., Gottlieb, 1985 Wethington & Kessler 1986 r Cohen & Wills,
2014 25 1 1 11 1 3,085 100 1 1988 e.g., 2000 3 e.g., 2005; 1999 100 1960 100 2012 2 6 23 1 98.2 1999 1999 3 65.3 1999 1996 1 21 e.g., 1999 3 1 2 251 Barrera, 1986; 1993 1 2 2001 3 2001 Barrera, 1981 1993
後ろ.indd
2010 p.1-42 2010 7 The relation between food intake of pregnant women and fetal growth -case sutudy- Vol.11 No.3 p.481-4862010 11 The 10th Hamamatsu-kyungpook Joint Medical Symposium, p.54, School of Medicine,Kyugpook
() ( 2 1)90 (2010) ( 1) QIAGEN DNeasy Blood & Tissue Handbook FAVORGEN Tissue Genomic DNA Extract
2012 (Sekiya et al 2012) ( ) ( 1) 1 1. 2010 2012 2013 2014 6 () 2014 8 29 481 ( 2 1)90 (2010) 461 20 5 5 35 ( 1) QIAGEN DNeasy Blood & Tissue Handbook FAVORGEN Tissue Genomic DNA Extraction Mini Kit DNA
NL10
Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9
32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5
8 8.1 Lieberman; db Kisilevsky; 1989 Hartikainen; db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; ,000 2,500g 13 Lagers
8 8.1 Lieberman; 1975 100 105 db Kisilevsky; 1989 Hartikainen; 1994 78 db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; 1978 713 40,000 2,500g 13 Lagerstrom et al.; 1991 Rantakallio; 1985, McDermott et al.;
平成27年度三菱重工グループ保険 フルガードくん（シニア）
TEL 0120-004-443 TEL 045-200-6560 TEL 042-761-2328 TEL 0120-539-022 TEL 042-762-0535 TEL 052-565-5211 TEL 077-552-9161 TEL 0120-430-372 TEL 0120-45-9898 TEL 0120-63-0051 TEL 0120-252-892 TEL 083-266-8041
野岩鉄道の旅
29th 5:13 5:34 5:56 6:00 6:12 6:20 6:21 6:25 6:29 6:31 6:34 6:38 6:40 6:45 6:52 6:56 7:01 7:07 7:11 7:32 7:34 7:50 7:58 8:03 8:17 8:36 8:44 5:50 5:54 6:15 6:38 6:39 6:51 6:59 6:59 7:03 7:08 7:08 7:11 7:15
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
Ｎｏ．１９
Views and Actions C Points of View boxwhisker plot EU ICH http wwwinfopmdagojp n n n n n n No n n n n n n pi pii pi pii pi pii n n n PKPD No HTBD HTBD CD LHRH RS HTBD EGFR AT DMARD HTBD HTBD TNFα α HMGCoA
<91E6825289F1938C966B95FA8ECB90FC88E397C38B5A8F708A778F7091E589EF8EC08D7388CF88F5837D836A83858341838B566572312E696E6464>
2002 (1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (6) (7) (8) (1) (2) (3) (4) (1) (2) (3) (4) (5) (6) (7) (8) No 2,500 3 200 200 200 200 200 50 200 No, 3 1 2 00 No 2,500 200 7 2,000 7
-26-
-25- -26- -27- -28- -29- -30- -31- -32- -33- -34- -35- -36- -37- -38- cm -39- -40- 1 2 3 4 4 3 2 1 5 5-41- -42- -43- -44- -45- -46- -47- -48- -49- -50- cm -51- -52- -53- -54- -55- -56- -57- -58- -59- -60-
untitled
() () () () () ( ) () ( ) () ( ) () 2 () () 2 () () ( ) () () () 2 () () 2 3 ( ) () ( ) 2 3 4 () () 2 3 4 () () ( )( ) ( ) 2 ( ) 3 () () 2 3 () () 2 3 () () () () () () () () (( ) ( ) (( ))( )( ) ) 2 3
180 30 30 180 180 181 (3)(4) (3)(4)(2) 60 180 (1) (2) 20 (3)
12 12 72 (1) (2) (3) 12 (1) (2) (3) (1) (2) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (1) (2) 180 30 30 180 180 181 (3)(4) (3)(4)(2) 60 180 (1) (2) 20 (3) 30 16 (1) 31 (2) 31 (3) (1) (2) (3) (4) 30
... 6 1) 2) No. 01 02 03 04 05 06 07 08 09 10 11 12 No. 1 2 2 3 3cm 4 untitled
1....1 2....2 2.1...2 2.2...2 3....14 3.1...14 3.2...14 4....15 4.1...15 4.2...18 4.3...21 4.4...23 4.5...26 5....27 5.1...27 5.2...35 5.3...54 5.4...64 5.5...75 6....79 6.1...79 6.2...85 6.3...94 6.4...
113 120cm 1120cm 3 10cm 900 500+240 10 1 2 3 5 4 5 3 8 6 3 8 6 7 6 8 4 4 4 4 23 23 5 5 7
untitled
21 14 487 2,322 2 7 48 4 15 ( 27) 14 3(1867) 3 () 1 2 3 ( 901923 ) 5 (1536) 3 4 5 6 7 8 ( ) () () 9 10 21 11 12 13 14 16 17 18 20 1 19 20 21 22 23 21 22 24 25 26 27 28 22 5 29 30cm 7.5m 1865 3 1820 5
1948 1907 4024 1925 14 19281929 30 111931 4 3 15 4 16 3 15 4 161933 813 1935 12 17 11 17 1938 1945 2010 14 221 1945 10 1946 11 1947 1048 1947 1949 24
15 4 16 1988 63 28 19314 29 3 15 4 16 19283 15294 16 1930 113132 3 15 4 16 33 13 35 12 3 15 4 16 1945 10 10 10 10 40 1948 1907 4024 1925 14 19281929 30 111931 4 3 15 4 16 3 15 4 161933 813 1935 12 17 11
裁定審議会における裁定の概要 (平成23年度)
23 23 23 4 24 3 10 11 12 13 14 () 1 23 7 21 23 12 14 (19 ) 30 1.876% 60 8 24 19 78 27 1 (10) 37 (3) 2 22 9 21 23 5 9 21 12 1 22 2 27 89 10 11 6 A B 3 21 12 1 12 10 10 12 5 1 9 1 2 61 ( 21 10 1 11 30 )
Microsoft Word - 入居のしおり.doc
1 1 2 2 2 3 2 4 3 5 3 6 3 7 3 8 4 1 7 2 7 3 7 4 8 5 9 6 9 7 10 8 10 9 11 10 11 11 11 12 12 13 13 1 14 2 17 3 18 4 19 5 20 6 22 (1) 24 (2) 24 (3) 24 (4) 24 (5) 24 (6) 25 (7) 25 (8) 25 (9) 25 1 29 (1) 29
和県監査H15港湾.PDF
...1...1...1...1...1...1...1...1...2...2...2...3...3...3...5...5...10...11...12...13...13...13...14...14...14...14...14...14...15...15...15...15...15 ...16...17 14...17...18...18...19...21...23 2...25...27...27...28...28...28
( )
( ) () () 3 cm cm cm cm cm cm 1000 1500 50 500 1000 1000 1500 1000 10 50 300 1000 2000 1000 1500 50 10 1000 2000 300 50 1000 2000 1000 1500 50 10 1000 2000 300 30 10 300 1000 2000 1000 1500 1000
-1- 4 1 2 4-2- -- 2 2 cm 0 80cm 2 80cm 80cm 80cm 50cm 80cm 50cm 6 80cm 100 50 50 cm 10 6 4 50cm 4 4 50cm -4- -5- cm 50cm 4 4 4 50cm 50cm 4 80cm 50cm 80cm 50cm 6 cm -6- 20 250cm 1 2 1 4 0cm 60cm cm cm 1
河川砂防技術基準・基本計画編.PDF
4 1 1 1 1 1 2 1 2.1 1 2.2 2 2.3 2 2.4 2 3 2 4 3 2 4 1 4 1.1 4 1.2 4 2 4 2.1 4 2.2 4 2.3 5 2.4 5 2.5 5 2.5.1 5 2.5.2 5 2.6 5 2.6.1 5 2.6.2 5 2.6.3 5 2.6.4 5 2.6.5 6 2.7 6 2.7.1 6 2.7.2 6 2.7.3 6 2.7.4
4 100g
100g 10 20 30 40 50 60 70 80 4 5 7 9 12 15 19 24 60 100 10 80 100 20 10 5 20 195 20-1- 60 60 15 100 60 100 15 15 15 100 15 15 60 100 10 60 100 100 15 10 10 60 100 15 10 15 10 5-2- 80 80 24 100 80 100 24